webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

MAC glucuronide linker-1

  CAS No.: 2222981-71-5   Cat No.: BADC-01085   Purity: ≥95.0% 4.5  

MAC glucuronide linker-1 is an enzyme-cleavable ADC linker designed for selective drug release in tumor microenvironments, enhancing targeted delivery and therapeutic efficacy in antibody-drug conjugates.

MAC glucuronide linker-1

Structure of 2222981-71-5

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C42H47N3O17S
Molecular Weight
897.90
Shipping
Room temperature
Storage
Store at -5°C,keep in dry and avoid sunlight.

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
methyl (2S,3S,4S,5R,6S)-3,4,5-triacetyloxy-6-[2-[[2-[9H-fluoren-9-ylmethoxycarbonyl(methyl)amino]acetyl]amino]-4-(2-methylsulfonylethylcarbamoyloxymethyl)phenoxy]oxane-2-carboxylate
IUPAC Name
methyl (2S,3S,4S,5R,6S)-3,4,5-triacetyloxy-6-[2-[[2-[9H-fluoren-9-ylmethoxycarbonyl(methyl)amino]acetyl]amino]-4-(2-methylsulfonylethylcarbamoyloxymethyl)phenoxy]oxane-2-carboxylate
Canonical SMILES
CC(=O)OC1C(C(OC(C1OC(=O)C)OC2=C(C=C(C=C2)COC(=O)NCCS(=O)(=O)C)NC(=O)CN(C)C(=O)OCC3C4=CC=CC=C4C5=CC=CC=C35)C(=O)OC)OC(=O)C
InChI
InChI=1S/C42H47N3O17S/c1-23(46)58-35-36(59-24(2)47)38(60-25(3)48)40(62-37(35)39(50)55-5)61-33-16-15-26(21-56-41(51)43-17-18-63(6,53)54)19-32(33)44-34(49)20-45(4)42(52)57-22-31-29-13-9-7-11-27(29)28-12-8-10-14-30(28)31/h7-16,19,31,35-38,40H,17-18,20-22H2,1-6H3,(H,43,51)(H,44,49)/t35-,36-,37-,38+,40+/m0/s1
InChIKey
HKCMXFVQNGHVML-KWMSUFDQSA-N
Solubility
10 mm in DMSO
Appearance
Solid
Shelf Life
0-4°C for short term (days to weeks), or -20°C for long term (months).
Shipping
Room temperature
Storage
Store at -5°C,keep in dry and avoid sunlight.
Form
Solid
Biological Activity
MAC glucuronide linker-1 is a nonclaevable ADC linker for antibody-drug-conjugations (ADCs)[1]

MAC glucuronide linker-1 is a specialized chemical compound commonly utilized in the development of antibody-drug conjugates (ADCs). This linker is known for its stability and ability to facilitate the controlled release of the cytotoxic drug payload at the target site. In ADC formulations, MAC glucuronide linker-1 plays a critical role by connecting the antibody to the drug while maintaining the integrity of the conjugate during circulation. Once the ADC reaches the targeted cancer cells, the linker is cleaved by specific enzymes, such as glucuronidase, enabling the release of the cytotoxic agent in the tumor microenvironment. This controlled release is essential for reducing off-target toxicity and improving therapeutic efficacy.

Another significant application of MAC glucuronide linker-1 is in the development of targeted therapies for diseases beyond cancer, including viral infections. Due to its stable yet cleavable nature, it is being explored for the delivery of antiviral agents. The glucuronide linkage provides a means to selectively activate the therapeutic agent at the site of infection, ensuring that the drug is released only in the vicinity of the virus. This enhances the precision of treatment, minimizing systemic side effects and optimizing therapeutic outcomes.

In addition to its use in ADCs and antiviral therapies, MAC glucuronide linker-1 is also being studied for its potential in drug delivery systems that target specific tissues or organs. Its ability to link therapeutic compounds to carrier molecules, such as nanoparticles, enables more effective delivery to specific sites in the body. This has promising implications in the treatment of diseases like rheumatoid arthritis or cardiovascular conditions, where localized delivery of drugs could dramatically improve efficacy and reduce the risk of side effects associated with systemic drug administration.

What is the purpose of MAC glucuronide linker-1 in ADCs?

MAC glucuronide linker-1 is an enzymatically cleavable linker that releases payloads upon exposure to β-glucuronidase. This design allows controlled intracellular drug release in targeted cells while maintaining antibody stability during circulation.

12/3/2019

Dear team, how should MAC glucuronide linker-1 be stored?

MAC glucuronide linker-1 should be stored at -20°C under inert atmosphere and protected from moisture. Proper storage preserves the glucuronide moiety and ensures predictable enzymatic cleavage in ADC applications.

10/11/2022

Could you kindly advise which conjugation strategies are compatible with MAC glucuronide linker-1?

It can be conjugated to antibodies via amine-reactive or thiol-reactive chemistry. The linker is compatible with various payloads, allowing modular ADC synthesis and controlled drug release in the presence of β-glucuronidase.

5/11/2018

Dear team, is MAC glucuronide linker-1 suitable for in vivo ADC studies?

Yes, MAC glucuronide linker-1 has been applied in preclinical ADC research. Its enzymatic cleavability ensures targeted payload release in tumor cells with β-glucuronidase activity, reducing systemic toxicity while maintaining antibody integrity.

21/8/2021

Dear team, which supporting documentation is provided with MAC glucuronide linker-1?

MAC glucuronide linker-1 is supplied with a certificate of analysis (CoA) that includes identity confirmation, structural characterization, and recommended handling instructions. Analytical data such as NMR, MS, and HPLC are typically provided to verify linker integrity and ensure suitability for antibody-drug conjugation applications.

1/2/2017

— Dr. Emily Carter, Senior Scientist (USA)

We required a specialized linker for our ADC program, and MAC glucuronide linker-1 met all specifications. The purity and consistency were excellent, which significantly improved our conjugation efficiency.

5/11/2018

— Prof. David Müller, Medicinal Chemist (Germany)

The custom synthesis of MAC glucuronide linker-1 was delivered on time, and its stability under storage conditions exceeded our expectations. Highly recommended.

1/2/2017

— Dr. Anna Rossi, Bioconjugation Specialist (Italy)

Excellent batch-to-batch consistency of MAC glucuronide linker-1 allowed us to scale our ADC development without delays. Quality is outstanding.

21/8/2021

— Mr. James Thompson, R&D Manager (UK)

BOC Sciences’ MAC glucuronide linker-1 offered superior solubility and reactivity, which improved our ADC yield significantly. Communication throughout the process was seamless.

12/3/2019

— Dr. Laura Jensen, ADC Project Lead (Denmark)

Using MAC glucuronide linker-1, we observed minimal side reactions during conjugation. The product was exactly as described and reproducible across multiple experiments.

— Ms. Sophie Martin, Senior Researcher (France)

The linker quality and delivery timeline for MAC glucuronide linker-1 were exceptional. It greatly facilitated our high-throughput ADC screening.

10/11/2022

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: MAC glucuronide linker-1 | APN-PEG4-DBCO
Send Inquiry
Verification code
Inquiry Basket